Severe Liver Injury Triggered by Sequential Use of Immune Checkpoint Blockers and Tyrosine Kinase Inhibitors: An Emerging Clinical Issue

Severe Liver Injury Triggered by Sequential Use of Immune Checkpoint Blockers and Tyrosine Kinase Inhibitors: An Emerging Clinical Issue

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thoracic oncology 2023-10, Vol.18 (10), p.e112-e113
Hauptverfasser: Gelsomino, Francesco, Vitale, Giovanni, Raschi, Emanuel, Ardizzoni, Andrea
Format: Artikel
Sprache:eng
Schlagworte:
Antineoplastic Agents, Immunological
Humans
Immune Checkpoint Inhibitors
Liver
Lung Neoplasms
Protein Kinase Inhibitors - adverse effects
Tyrosine Kinase Inhibitors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e113
container_issue 10
container_start_page e112
container_title Journal of thoracic oncology
container_volume 18
creator Gelsomino, Francesco
Vitale, Giovanni
Raschi, Emanuel
Ardizzoni, Andrea
description
doi_str_mv 10.1016/j.jtho.2023.07.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2871653733</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1556086423006676</els_id><sourcerecordid>2871653733</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-406e4681dcac0e8dc58d6e7ea5ce16a641714214ff1162a611c92dd434af13043</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhSMEoqXlD3BAPnLZMI4dxyAuZdVCxEo9dHu2vPZk12liL3ZSaf8BP7te7cKR04xG33vSm1cUHyiUFKj43Jf9tAtlBRUroSkBqlfFJa1rsaBMwuvzDlLwi-JdSj0Ar4HLt8UFa5paMi4viz8P-IwRycrlQVrfz_FA1tFtt_lqyeZAHvD3jH5yeiCPCUnoSDuOs0ey3KF52gfnJ_J9COYJYyLaW7I-xJBcBn45r7Oi9Tu3cVOI6Su58eR2xLh1fkuWg_POZNs2pRmvizedHhK-P8-r4vHudr38uVjd_2iXN6uF4QDTgoNALiS1RhtAaU0trcAGdW2QCi04bSivKO86SkWlBaXmS2UtZ1x3lAFnV8Wnk-8-hhwsTWp0yeAwaI9hTqqSDRU1axjLaHVCTQ6UInZqH92o40FRUMcGVK-ODahjAwoalRvIoo9n_3kzov0n-fvyDHw7AZhTPjuMKhmH3qB1Ec2kbHD_838Bc2eYfA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2871653733</pqid></control><display><type>article</type><title>Severe Liver Injury Triggered by Sequential Use of Immune Checkpoint Blockers and Tyrosine Kinase Inhibitors: An Emerging Clinical Issue</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Gelsomino, Francesco ; Vitale, Giovanni ; Raschi, Emanuel ; Ardizzoni, Andrea</creator><creatorcontrib>Gelsomino, Francesco ; Vitale, Giovanni ; Raschi, Emanuel ; Ardizzoni, Andrea</creatorcontrib><identifier>ISSN: 1556-0864</identifier><identifier>EISSN: 1556-1380</identifier><identifier>DOI: 10.1016/j.jtho.2023.07.002</identifier><identifier>PMID: 37758348</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Antineoplastic Agents, Immunological ; Humans ; Immune Checkpoint Inhibitors ; Liver ; Lung Neoplasms ; Protein Kinase Inhibitors - adverse effects ; Tyrosine Kinase Inhibitors</subject><ispartof>Journal of thoracic oncology, 2023-10, Vol.18 (10), p.e112-e113</ispartof><rights>2023 International Association for the Study of Lung Cancer</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-406e4681dcac0e8dc58d6e7ea5ce16a641714214ff1162a611c92dd434af13043</citedby><cites>FETCH-LOGICAL-c400t-406e4681dcac0e8dc58d6e7ea5ce16a641714214ff1162a611c92dd434af13043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37758348$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gelsomino, Francesco</creatorcontrib><creatorcontrib>Vitale, Giovanni</creatorcontrib><creatorcontrib>Raschi, Emanuel</creatorcontrib><creatorcontrib>Ardizzoni, Andrea</creatorcontrib><title>Severe Liver Injury Triggered by Sequential Use of Immune Checkpoint Blockers and Tyrosine Kinase Inhibitors: An Emerging Clinical Issue</title><title>Journal of thoracic oncology</title><addtitle>J Thorac Oncol</addtitle><subject>Antineoplastic Agents, Immunological</subject><subject>Humans</subject><subject>Immune Checkpoint Inhibitors</subject><subject>Liver</subject><subject>Lung Neoplasms</subject><subject>Protein Kinase Inhibitors - adverse effects</subject><subject>Tyrosine Kinase Inhibitors</subject><issn>1556-0864</issn><issn>1556-1380</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFv1DAQhSMEoqXlD3BAPnLZMI4dxyAuZdVCxEo9dHu2vPZk12liL3ZSaf8BP7te7cKR04xG33vSm1cUHyiUFKj43Jf9tAtlBRUroSkBqlfFJa1rsaBMwuvzDlLwi-JdSj0Ar4HLt8UFa5paMi4viz8P-IwRycrlQVrfz_FA1tFtt_lqyeZAHvD3jH5yeiCPCUnoSDuOs0ey3KF52gfnJ_J9COYJYyLaW7I-xJBcBn45r7Oi9Tu3cVOI6Su58eR2xLh1fkuWg_POZNs2pRmvizedHhK-P8-r4vHudr38uVjd_2iXN6uF4QDTgoNALiS1RhtAaU0trcAGdW2QCi04bSivKO86SkWlBaXmS2UtZ1x3lAFnV8Wnk-8-hhwsTWp0yeAwaI9hTqqSDRU1axjLaHVCTQ6UInZqH92o40FRUMcGVK-ODahjAwoalRvIoo9n_3kzov0n-fvyDHw7AZhTPjuMKhmH3qB1Ec2kbHD_838Bc2eYfA</recordid><startdate>202310</startdate><enddate>202310</enddate><creator>Gelsomino, Francesco</creator><creator>Vitale, Giovanni</creator><creator>Raschi, Emanuel</creator><creator>Ardizzoni, Andrea</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202310</creationdate><title>Severe Liver Injury Triggered by Sequential Use of Immune Checkpoint Blockers and Tyrosine Kinase Inhibitors: An Emerging Clinical Issue</title><author>Gelsomino, Francesco ; Vitale, Giovanni ; Raschi, Emanuel ; Ardizzoni, Andrea</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-406e4681dcac0e8dc58d6e7ea5ce16a641714214ff1162a611c92dd434af13043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antineoplastic Agents, Immunological</topic><topic>Humans</topic><topic>Immune Checkpoint Inhibitors</topic><topic>Liver</topic><topic>Lung Neoplasms</topic><topic>Protein Kinase Inhibitors - adverse effects</topic><topic>Tyrosine Kinase Inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gelsomino, Francesco</creatorcontrib><creatorcontrib>Vitale, Giovanni</creatorcontrib><creatorcontrib>Raschi, Emanuel</creatorcontrib><creatorcontrib>Ardizzoni, Andrea</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of thoracic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gelsomino, Francesco</au><au>Vitale, Giovanni</au><au>Raschi, Emanuel</au><au>Ardizzoni, Andrea</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Severe Liver Injury Triggered by Sequential Use of Immune Checkpoint Blockers and Tyrosine Kinase Inhibitors: An Emerging Clinical Issue</atitle><jtitle>Journal of thoracic oncology</jtitle><addtitle>J Thorac Oncol</addtitle><date>2023-10</date><risdate>2023</risdate><volume>18</volume><issue>10</issue><spage>e112</spage><epage>e113</epage><pages>e112-e113</pages><issn>1556-0864</issn><eissn>1556-1380</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>37758348</pmid><doi>10.1016/j.jtho.2023.07.002</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1556-0864
ispartof Journal of thoracic oncology, 2023-10, Vol.18 (10), p.e112-e113
issn 1556-0864
1556-1380
language eng
recordid cdi_proquest_miscellaneous_2871653733
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Antineoplastic Agents, Immunological
Humans
Immune Checkpoint Inhibitors
Liver
Lung Neoplasms
Protein Kinase Inhibitors - adverse effects
Tyrosine Kinase Inhibitors
title Severe Liver Injury Triggered by Sequential Use of Immune Checkpoint Blockers and Tyrosine Kinase Inhibitors: An Emerging Clinical Issue
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T18%3A02%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Severe%20Liver%20Injury%20Triggered%20by%20Sequential%20Use%20of%20Immune%20Checkpoint%20Blockers%20and%20Tyrosine%20Kinase%20Inhibitors:%20An%20Emerging%20Clinical%20Issue&rft.jtitle=Journal%20of%20thoracic%20oncology&rft.au=Gelsomino,%20Francesco&rft.date=2023-10&rft.volume=18&rft.issue=10&rft.spage=e112&rft.epage=e113&rft.pages=e112-e113&rft.issn=1556-0864&rft.eissn=1556-1380&rft_id=info:doi/10.1016/j.jtho.2023.07.002&rft_dat=%3Cproquest_cross%3E2871653733%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2871653733&rft_id=info:pmid/37758348&rft_els_id=S1556086423006676&rfr_iscdi=true